Autologous Cytokine-induced Killer Cell Combination Therapy Enhances Response to Immune Checkpoint Inhibitors in Patients with Refractory Clear Cell Renal Cell CarcinomaShuzhan Li, Xiubao Ren, Jing Qin et al.|Research Square|2025Cited by 0
Camrelizumab with or without Autologous Cytokine-induced Killer Cell Therapy in Patients with Refractory Clear Cell Renal Cell Carcinoma: A Randomized Pilot StudyShuzhan Li, Xiubao Ren, Yanjuan Xiong et al.|Research Square|2025Cited by 0